Frønsdal, KB, Facey, K, Klemp, M, et al.
Health technology assessment to optimize health technology utilization: Using implementation initiatives and monitoring processes. Int J Technol Assess Health Care.
Henshall, C, Schuller, T; HTAi Policy Forum. Health technology assessment, value-based decision making, and innovation. Int J Technol Assess Health Care.
Mossialos, E, Wenzl, M, Osborn, R, Sarnak, D, eds. International profiles of health care systems, 2015 [Internet]. The Commonwealth Fund; 2016 [cited March 14, 2016]. http://www.commonwealthfund.org/publications/fund-reports/2016/jan/international-profiles-2015
Facey, K. Improving the effectiveness and efficiency of evidence production for HTA in the light of current trends in drug and device development, health system funding, regulation and HTA. Int J Technol Assess Health Care.
Dirksen, CD. The use of research evidence on patient preferences in health care decision-making: Issues, controversies and moving forward. Expert Rev Pharmacoecon Outcomes Res.
Ward, JW, Mermin, JH. Simple, effective, but out of reach? Public health implications of HCV drugs. N Engl J Med.
Eichler, H-G, Pignatti, F, Flamion, B, Leufkens, H, Breckenridge, A. Balancing early market access to new drugs with the need for benefit/risk data: A mounting dilemma. Nat Rev Drug Discov.
Husereau, D, Henshall, C, Jivrai, J. Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices. Int J Technol Assess Health Care.
Klemp, M, Frønsdal, KB, Facey, K. What principles should govern the use of managed entry agreements?
Int J Technol Assess Health Care.
Montilla, S, Xoxi, E, Russo, P, Cicchetti, A, Pani, L. Monitoring registries at Italian medicines agency: fostering access, guaranteeing sustainability. Int J Technol Assess Health Care.
Facey, KM, Hansen, HP. Patient-focused HTAs. Int J Technol Assess Health Care.
Frank, L, Forsythe, L, Ellis, L, et al.
Conceptual and practical foundations of patient engagement in research at the patient-centered outcomes research institute. Qual Life Res.
Eichler, H-G, Bloechl-Daum, B, Abadie, E, et al.
Relative efficacy of drugs: An emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov.
Lord, J, Willis, S, Eatock, J, et al.
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: The Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Health Technol Assess.
Noorani, HZ, Husereau, DR, Boudreau, R, Skidmore, B. Priority setting for health technology assessments: A systematic review of current practical approaches. Int J Technol Assess Health Care.
Low, E. Potential for patients and patient-driven organizations to improve evidence for health technology assessment. Int J Technol Assess Health Care.
Moreira, T. Understanding the role of patient organizations in health technology assessment. Health Expect.
Whitty, JA. An international survey of the public engagement practices of health technology assessment organizations. Value Health.
Husereau, D. How do we value a cure?
Expert Rev Pharmacoecon Outcomes Res.
Coyle, D, Buxton, MJ, O'Brien, BJ. Stratified cost-effectiveness analysis: A framework for establishing efficient limited use criteria. Health Econ.
Carlson, JJ, Sullivan, SD, Garrison, LP, Neumann, PJ, Veenstra, DL. Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy.
Daniels, N, Porteny, T, Urritia, J. Expanded HTA: Enhancing fairness and legitimacy. Int J Health Policy Manag.
Thokala, P, Duenas, A. Multiple criteria decision analysis for health technology assessment. Value Health.
Diaby, V, Goeree, R. How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: A step-by-step guide. Expert Rev Pharmacoecon Outcomes Res.
Thokala, P, Devlin, N, Marsh, K, et al.
Multiple criteria decision analysis for health care decision making–An introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health.
Henshall, C, Schuller, T, Mardhani-Bayne, L. Using health technology assessment to support optimal use of technologies in current practice: The challenge of “disinvestment.” Int J Technol Assess Health Care.
Garber, AM. Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-284-296.